• Samina Karim
  • Sabiha Karim
  • Almas Begum
  • Nasreen Javed


Background: Hypertension has long been recognized as the major risk factor for the development of coronary disease.It was found that the combination of thiazide diuretic and ACE inhibitor has favorable antihypertensive and metaboliceffect i.e the combination reduces the levels of lipid. Methods: 40 women aged between 35-60 years having systolicblood pressure equal to or greater then 160mmHg were included in the study. Captopril in a dose of 25-75 mg plusthiazide 25-50mg orally per day was given in divided doses. Before starting therapy and then after 4 and 10 week oftherapy, 5ml of fasting blood was drawn to analyze lipid profile like serum triglyceride, cholesterol and lipoprotein(HDL and LDL-Cholesterol). Results: Study observed a marked decrease of blood pressure after taking captopril withdiuretics. Level of triglyceride and of HDL and LDL-cholesterol were also significantly changed (P<0.01) ascompared to their controls. Conclusion: It was observed that captopril in combination of thiazide diuretics not onlydecrease blood pressure but also a beneficial effect on lipid profile. Hence further research is needed on large numberof patients of both sexes.


Bjornturp P, Holm G, Rosmond R, Follow B Hypertension

and the metabolic syndrome: closely related central origin1

Blood Press 2000, 9:91-7

Guyton AC Text Book of Physiology. 8lh ed W B Saunders

Go, Philadelphia 1997,256-70

Kubo T. Yamaguchi H. Tsujimura M Hagiwara Y. Fukumon

R. An angiotensin system in the anterior hypothalamic area

anterior is involved in the maintenance of hypertension in

spontaneously hypertensive rats Brain Res Bull 2®. 52 291-

Prichard BN, Graham BR. Cruickshank JM. A new approach

to the uses of beta blocking drugs in hypertension J Hum

Hypert 2000,9 285-92

Haslet C, Chilvers BR, Hunter JAA. Bonn NA David son J

Principle and Practice of Medicine 18th ed Churchill Living

Stone Edinburg 1099. 800-802

Hinkin T. Come JA Secondary dyshpidemia. In adverse

effect of drug in clinical practice. JAMA. .1992,267

Devlin TM. Textbook of Biochemistry with

c o r r e l a t i o n . Widely Medical Publication, New 210-


W.H.O. World Health Organization, technical WHO.

Arterial hypertension, Report of Committee 1978, Technical

Report Series.

Puddy IB. Large multicentre hypertension trials. Curr Opin

Nephrol Hypertens 2000 May;9(3):285-92

Rodriguez-Garcia JL, Villa E. Serrano M, Gallardo J.

Garcia-Robles R Prostacyclin: its pathogenic role in

essential hypertension and the class effect of ACE inhibitors

on prostaglandin metabolism. Blood Press 1999.8(5-6):279-

Cheung R. Lewanczuk RZ. Rodger NW. Huff MW. OddouStock P. Bolteri F. Pecher E. Muirhead N The effect of

valsartan and captopril on lipid parameters in patients with

type II diabetes mellitus and nephropathy hit J Clin Pract


Lopez R. Taboada C San Miguel A. Metabolic effects in rats

of verapamil alone and in combination with captopril Comp

Biochem Physiol C Pharmacol Toxicol Endocrinol 1997

Scemama M Fevrier B, Beucler I, Dairou F. Lipid profile

and antihypertensive efficacy in hyperlipidemic

hypertensive patients: comparison of rilmenidine and

captopril. J Cardiovac Pharmacol 1995;26 Suppl 2: S34-9

Vangelova K. Deyanov C. Dyslipoproteinemias in industrial

workers: relationship with hypertension and overweight.

Cent Eur Public Health 2000 May;8(2):77-9

Larsen CI. Serum C, Hansen JF, Jensen HA, Rasmussen V.

Blood pressure level and relation to other cardiovascular risk

factors in male hypertensive patients without clinical

evidence of ischemic heart disease. Blood Press 2000,9(2-

: 91-7